好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2013 Annual Meeting | S41 - Cerebrovascular Disease: Genetics and Biomarkers

Thursday 03/21/13
12:00 PM - 01:45 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Platform Session
Cerebrovascular Disease and Interventional Neurology
No CME available
Event Timeline
12:00 PM - 01:45 PM Abstract 001 - Serial MRI Findings in a Phase 2B Clinical Trial of Normobaric Oxygen Therapy (NBO) in Acute Ischemic Stroke (AIS)
Aneesh B. Singhal, MD, FAAN
12:00 PM - 01:45 PM Abstract 002 - Common Variants within Oxidative Phosphorylation Genes Influence Risk of Ischemic Stroke and Intracerebral Hemorrhage
Christopher D. Anderson, MD, PhD, FAAN
12:00 PM - 01:45 PM Abstract 003 - Amino Terminal Pro-B-Type Natriuretic Peptide, Secondary Stroke Prevention, and Choice of Antithrombotic Therapy
Mitchell S. Elkind, MD, MS, FAAN
12:00 PM - 01:45 PM Abstract 004 - The BDNF Val66Met Polymorphism Influences Motor System Function and Plasticity after Stroke
12:00 PM - 01:45 PM Abstract 005 - SNP rs10940495 in the Gp-130 Locus Is Associated with Functional Outcome Following Spontaneous Intracerebral Hemorrhage
Nada El Husseini, MD, FAAN
12:00 PM - 01:45 PM Abstract 006 - Genomic Analysis of Leukocyte mRNA Suggests Immune Predisposition to Hemorrhagic Transformation in Ischemic Stroke
Glen Jickling, MD
12:00 PM - 01:45 PM Abstract 007 - Increased von Willebrand Factor Propeptide Levels in Symptomatic Versus Asymptomatic Moderate and Severe Carotid Artery Stenosis - Results from the Platelets and Carotid Stenosis (PACS) Study
Justin Kinsella, MD
Faculty Disclosures
No disclosure on file
Robin L. Brey, MD The institution of Dr. Brey has received research support from State of Texas. Dr. Brey has a non-compensated relationship as a Task Force Member with AAN that is relevant to AAN interests or activities.
Joseph P. Broderick, MD, FAAN Dr. Broderick has received publishing royalties from a publication relating to health care.
Thomas G. Brott, MD, FAAN Dr. Brott has nothing to disclose.
Larry B. Goldstein, MD, FAHA, FAAN The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from Janssen. Dr. Goldstein has received publishing royalties from a publication relating to health care.
Costantino Iadecola, MD Dr. Iadecola has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Broadview Ventures.
Steven Levine, MD, FAHA Dr. Levine has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MEDLINK. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Law Firms. The institution of Dr. Levine has received research support from NIH.
W. T. Longstreth, Jr., MD, FAAN The institution of Dr. Longstreth has received research support from NIH.
J. P. Mohr, MD, FAAN The institution of Dr. Mohr has received research support from NINDS Grant R01 NS099268 NIH-NINDS .
Frank R. Sharp, MD No disclosure on file
Piero Verro, MD No disclosure on file
Bruno Dubois, MD No disclosure on file
Reinhold Schmidt, MD No disclosure on file
Scott L. Silliman, MD Dr. Silliman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Steven M. Greenberg, MD, PhD, FAAN Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squib. The institution of Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Greenberg has received research support from National Institutes of Health. Dr. Greenberg has received publishing royalties from a publication relating to health care.
David L. Tirschwell, MD, FAAN Dr. Tirschwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. The institution of Dr. Tirschwell has received research support from Abbott. The institution of Dr. Tirschwell has received research support from NIH.
Karen L. Furie, MD The institution of Dr. Furie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/BMS. Dr. Furie has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ/JNNP. The institution of Dr. Furie has received research support from NINDS.
Daniel T. Laskowitz, MD No disclosure on file
Steven C. Cramer, MD, FAAN Dr. Cramer has received personal compensation for serving as an employee of University of California. An immediate family member of Dr. Cramer has received personal compensation for serving as an employee of University of California. Dr. Cramer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astellas, Alevian, Bayer, BlueRock Therapeutics, BrainQ, Constant Therapeutics, Medtronic, MicroTransponder, Myomo, Myrobalan, NeuroTrauma Sciences, Simcere, and TRCare. Dr. Cramer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MUSC. Dr. Cramer has stock in Constant Therapeutics, Panaxium, and TRCare. The institution of Dr. Cramer has received research support from NIH; PCORI; Veterans Administration.
James F. Meschia, MD, FAAN The institution of Dr. Meschia has received research support from NINDS. The institution of Dr. Meschia has received research support from NINDS.
Mitchell S. Elkind, MD, MS, FAAN Dr. Elkind has received personal compensation for serving as an employee of American Heart Association. Dr. Elkind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Atria Academy.
Jonathan Rosand, MD Dr. Rosand has received personal compensation for serving as an employee of Massachusetts General Hospital. Dr. Rosand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Rosand has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for National Football League. The institution of Dr. Rosand has received research support from NIH. The institution of Dr. Rosand has received research support from American Heart Association. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as a Peer reviewer with National Institutes of Health. Dr. Rosand has a non-compensated relationship as a Trustee with Columbia University that is relevant to AAN interests or activities.
Bradford B. Worrall, MD, MSc, FAAN The institution of Dr. Worrall has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Worrall has received research support from NIH. The institution of Dr. Worrall has received research support from AHA/ASA.
Daniel Woo, MD, FAAN The institution of Dr. Woo has received research support from NIH.
Chelsea S. Kidwell, MD No disclosure on file
Aneesh B. Singhal, MD, FAAN An immediate family member of Dr. Singhal has received personal compensation for serving as an employee of Biogen. Dr. Singhal has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Medicolegal Firms. Dr. Singhal has received research support from NIH-NINDS. Dr. Singhal has received publishing royalties from a publication relating to health care. Dr. Singhal has received publishing royalties from a publication relating to health care. Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving as a Honorarium (好色先生) with Biogen.
Magdy H. Selim, MD, PhD Dr. Selim has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedRhythms Inc..
Devin L. Brown, MD, FAAN The institution of Dr. Brown has received research support from NIH.
Colin Doherty, MD The institution of Dr. Doherty has received research support from UCB pharma. The institution of Dr. Doherty has received research support from Science foundation Ireland.
Natalia S. Rost, MD, MPH, FAAN, FAHA Dr. Rost has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for 好色先生. Dr. Rost has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke - AHA/ASA Journal. The institution of Dr. Rost has received research support from NIH. Dr. Rost has received publishing royalties from a publication relating to health care.
Agnieszka Slowik, MD, FAAN Dr. Slowik has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer, . Dr. Slowik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Slowik has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
John L. Thompson, PhD The institution of Dr. Thompson has received research support from NIH.
Jaume Roquer Gonzalez No disclosure on file
Michael L. James, MD Dr. James has nothing to disclose.
Raymond P. Murphy, FRCP No disclosure on file
Anand Viswanathan, MD Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam Pharmaceuticals. Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharmaceuticals.
Kristin Schwab No disclosure on file
Glen Jickling, MD No disclosure on file
Andrew Singleton An immediate family member of Andrew Singleton has received personal compensation for serving as an employee of GeneDx. Andrew Singleton has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Nature Partner Journals Parkinson Disease. Andrew Singleton has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Journal. An immediate family member of Andrew Singleton has stock in GeneDx. The institution of Andrew Singleton has received research support from Michael J Fox Foundation. Andrew Singleton has received intellectual property interests from a discovery or technology relating to health care. Andrew Singleton has received intellectual property interests from a discovery or technology relating to health care.
Edward C. Jauch, MD, MS, FAHA, FACEP No disclosure on file
Owen A. Ross, PhD Dr. Ross has nothing to disclose.
Christopher D. Anderson, MD, PhD, FAAN The institution of Dr. Anderson has received research support from Bayer AG. The institution of Dr. Anderson has received research support from American Heart Association. The institution of Dr. Anderson has received research support from National Institutes of Health. An immediate family member of Dr. Anderson has received publishing royalties from a publication relating to health care.
Nada El Husseini, MD, FAAN The institution of Dr. El Husseini has received research support from the DISCOVERY trial funded by the National Institute of Neurological Disorders and Stroke (NINDS)and the National Institute on Aging (NIA) (U19NS115388).- subcontract from MGH.
Joshua Goldstein Joshua Goldstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. The institution of Joshua Goldstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Joshua Goldstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrazeneca. The institution of Joshua Goldstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. The institution of Joshua Goldstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Joshua Goldstein has stock in NControl. Joshua Goldstein has stock in Cayuga. The institution of Joshua Goldstein has received research support from Pfizer. The institution of Joshua Goldstein has received research support from Takeda.
Justin Kinsella, MD Dr. Kinsella has nothing to disclose.
Dominick J. McCabe, MD, PhD No disclosure on file
W. O. Tobin, PhD, MBBCh, BAO, FAAN Dr. Tobin has received publishing royalties from a publication relating to health care.
Alessandro Biffi, MD Dr. Biffi has received personal compensation for serving as an employee of Eli Lilly And Company. Dr. Biffi has stock in Eli Lilly And Company.
Richard Buchsbaum No disclosure on file
Tania Nikolcheva No disclosure on file